Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.
Most entities can be simply and efficiently treated by repeated phlebotomies, provided an early diagnosis has been made. Molecular identification of the various HFEand non-HFEmutations represents ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback